SCHEMBL2862043

SCHEMBL2862043

CCc1c(O)cc(O)c(C(=O)c2ccc(O)cc2)c1CC(=O)N(CCO)CCO

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 7/20 0.36
EYA3 Q99504 2/20 0.36
LMNA P02545 2/20 0.34
HPGD P15428 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
HTT P42858 2/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
USP7 Q93009 1/20 0.33
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2864982 0.92 MLYCD (0.36) SLC22A12EYA3LMNAHPGDSMN1; SMN2
SCHEMBL2854718 0.91 POLB (0.42) LMNAHPGDSMN1; SMN2MEN1KMT2A
SCHEMBL2857183 0.90 L3MBTL1 (0.37) LMNAHPGDSMN1; SMN2MEN1KMT2A
SCHEMBL2856124 0.89 HPGD (0.38) SLC22A12HPGDHTTMAPTHSP90AA1
SCHEMBL2861241 0.89 ALDH1A1 (0.45) LMNAHPGDKMT2AMAPTMAPK1
SCHEMBL2861059 0.88 BCL2L1 (0.38) LMNAESR1
SCHEMBL2869158 0.88 GSR (0.36) LMNAHPGDSMN1; SMN2MEN1KMT2A
SCHEMBL2869161 0.87 CES2 (0.34) HPGDHSP90AA1HSP90AB1KDM4EALDH1A1
SCHEMBL2869154 0.87 HPGD (0.34) LMNAHPGDSMN1; SMN2MEN1KMT2A
SCHEMBL2860086 0.86 PARP10 (0.39) LMNAHPGDKMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1642880-B1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KIRIN CO LTD (JP) 2013-09-04 EP claimed
EP-1642880-B1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KIRIN CO LTD (JP) 2013-09-04 EP disclosed
US-7767693-B2 Hsp90 family protein inhibitors KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-08-03 US disclosed
US-20090247522-A1 Hsp90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-10-01 US disclosed
US-7538224-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070032532-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-02-08 US disclosed
EP-1642880-A1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-04-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032532-A1 Hsp90 family protein inhibitors HSP90AB1, HSP90B1, HSP90AB2P SLC22A12 1461/4885EYA3 3825/4885LMNA 4283/4885
US-20090247522-A1 Hsp90 FAMILY PROTEIN INHIBITORS HSP90AB1, HSP90B1, HSP90AB2P SLC22A12 1461/4885EYA3 3825/4885LMNA 4283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.